IN2015DN01855A - - Google Patents

Download PDF

Info

Publication number: IN2015DN01855A
Authority: IN; India
Prior art keywords: subject; micrornas; colorectal; suffering; expression pattern
Prior art date: 2011-10-21

Application number

Other languages

English (en)

Inventor

I Cos Meritxell Gironella

Salvatella Juan Jose Lozano

I Garangou Antoni Castells

Maria Dolores Giraldez

Original Assignee

Hospital Clinic Barcelona

Ct De Investigación Biomédica En Red De Enfermedades Hepáticas Y Digestivas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-10-21

Filing date

2012-10-20

Publication date

2015-07-10

2012-10-20 Application filed by Hospital Clinic Barcelona, Ct De Investigación Biomédica En Red De Enfermedades Hepáticas Y Digestivas filed Critical Hospital Clinic Barcelona

2015-07-10 Publication of IN2015DN01855A publication Critical patent/IN2015DN01855A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Pathology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)

IN1855DEN2015 2011-10-21 2012-10-20 IN2015DN01855A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161550148P	2011-10-21	2011-10-21
PCT/IB2012/003035 WO2013093635A2 (fr)	2011-10-21	2012-10-20	Microarn du plasma pour la détection du cancer colorectal précoce

Publications (1)

Publication Number	Publication Date
IN2015DN01855A true IN2015DN01855A (fr)	2015-07-10

Family

ID=48136439

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN1855DEN2015 IN2015DN01855A (fr)	2011-10-21	2012-10-20

Country Status (18)

Country	Link
US (6)	US20130102487A1 (fr)
EP (2)	EP2768986B1 (fr)
JP (2)	JP6159727B2 (fr)
KR (2)	KR101900872B1 (fr)
CN (2)	CN104145024A (fr)
AU (1)	AU2012356317B2 (fr)
BR (2)	BR112014009643B1 (fr)
CA (1)	CA2852850C (fr)
DK (2)	DK2944700T3 (fr)
ES (2)	ES2662401T3 (fr)
HU (2)	HUE035614T2 (fr)
IN (1)	IN2015DN01855A (fr)
MX (2)	MX357119B (fr)
NO (1)	NO3051026T3 (fr)
PL (2)	PL2944700T3 (fr)
PT (2)	PT2768986T (fr)
RU (2)	RU2662975C1 (fr)
WO (1)	WO2013093635A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2628355B2 (ja)	1987-09-22	1997-07-09	バクスター、インターナショナル、インコーポレイテッド	生理学的測定装置のための光ファイバープローブコネクター
CA2825522A1 (fr)	2011-01-26	2012-08-02	Cepheid	Procedes de detection du cancer du poumon
US20160040229A1 (en)	2013-08-16	2016-02-11	Guardant Health, Inc.	Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en)	2012-09-04	2020-12-29	Guardant Health, Inc.	Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en)	2012-09-04	2024-02-27	Guardent Health, Inc.	Systems and methods to detect rare mutations and copy number variation
GB2533006B (en)	2012-09-04	2017-06-07	Guardant Health Inc	Systems and methods to detect copy number variation
EP3771745A1 (fr)	2013-12-28	2021-02-03	Guardant Health, Inc.	Procédés et systèmes de détection de variants génétiques
US10260105B2 (en)	2014-02-18	2019-04-16	Baylor Research Institute	MiR-320e and colorectal cancer
CN106661619B (zh)	2014-06-13	2021-01-01	东丽株式会社	大肠癌的检测试剂盒或装置以及检测方法
WO2016034715A2 (fr) *	2014-09-05	2016-03-10	Prestizia	Methode de prediction de l'evolution clinique du cancer colorectal
CN104313142B (zh) *	2014-10-16	2016-02-03	上海交通大学医学院附属仁济医院	miRNA-30a作为标记分子在制备诊断试剂中的用途
CN104388541B (zh) *	2014-10-21	2017-07-04	复旦大学附属肿瘤医院	miR‑1914*和miR‑1915的用途
CN104372004B (zh) *	2014-12-04	2018-04-27	广东医学院	一个与心肌梗死易感相关的miR-27a基因单核苷酸多态位点的检测方法及其应用
CN107429295B (zh) *	2015-03-09	2022-09-30	新加坡科技研究局	通过检测微小RNA(miRNA)的表达水平来确定患乳腺癌的风险的方法
EP3147370A1 (fr) *	2015-09-28	2017-03-29	Rheinische Friedrich-Wilhelms-Universität Bonn	Micro-arn exosomal dans du sérum comme indicateur pour l'activation de graisse marron et beige tissu adipeux (bat)
EP3390668A4 (fr)	2015-12-17	2020-04-01	Guardant Health, Inc.	Procédés de détermination du nombre de copies du gène tumoral par analyse d'adn acellulaire
US20190185945A1 (en) *	2016-08-18	2019-06-20	University Of Technology Sydney	Biomarkers of Oral, Pharyngeal and Laryngeal Cancers
EP3327135A1 (fr) *	2016-11-28	2018-05-30	Advanced Marker Discovery, S.L.	Procédé in vitro d'identification d'adénomes colorectaux ou du cancer colorectal
CN106950370A (zh) *	2017-01-25	2017-07-14	上海市第十人民医院	血液微小核酸大肠癌诊断分子组合
CN107254522A (zh) *	2017-06-09	2017-10-17	中山大学附属第三医院	miR‑664a‑5p的检测试剂在制备肝癌诊断试剂/试剂盒中的应用
CN107236799B (zh) *	2017-06-15	2020-06-09	昆明医科大学第六附属医院	一种肾纤维化miRNA标记物
CN107326092B (zh) *	2017-08-25	2021-07-20	深圳市恩普电子技术有限公司	大肠癌相关的miRNA作为生物标志物的应用及大肠癌检测试剂盒
CN107746886B (zh) *	2017-09-11	2019-10-01	朱伟	一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用
WO2019144183A1 (fr) *	2018-01-23	2019-08-01	La Trobe University	Biomarqueurs du cancer colorectal
EP3752645A4 (fr)	2018-02-14	2022-04-13	Dermtech, Inc.	Nouveaux classificateurs de gènes et leurs utilisations dans des cancers de la peau sans mélanome
CN110205367B (zh) *	2018-02-28	2022-06-21	伽蓝（集团）股份有限公司	一种筛选保护皮肤细胞端粒的活性物的方法
CN112512440B (zh) *	2018-05-09	2024-07-09	德玛泰克公司	新型基因分类器及其在自身免疫性疾病中的用途
CN108753974B (zh) *	2018-06-27	2022-05-06	深圳华大生命科学研究院	一种结直肠癌肿瘤标志物及其检测方法与装置
CN109557311B (zh) *	2018-12-13	2022-02-15	中南大学湘雅医院	结直肠癌诊断标志物及结直肠癌的检测产品及其应用
KR102275465B1 (ko) *	2019-01-18	2021-07-09	사회복지법인 삼성생명공익재단	전이성 대장암 치료물질 스크리닝 방법
US20220145398A1 (en) *	2019-03-11	2022-05-12	The Chinese University Of Hong Kong	Mirna markers for colorectal cancer
WO2021009184A1 (fr) *	2019-07-15	2021-01-21	Institut D'investigacions Biomèdiques August Pi I Sunyer (Idibaps)	Procédé non invasif pour le diagnostic ou le criblage d'un cancer colorectal et/ou d'un stade précancéreux de celui-ci
CN110438227A (zh) *	2019-07-29	2019-11-12	广州中昱医学生物科技有限公司	miR-17-92在结直肠癌诊断中的用途
AU2020325690A1 (en)	2019-08-02	2022-03-03	Fundació De Recerca Clinic Barcelona-Institut D’Investigacions Biomèdiques August Pi I Sunyer	CAR T-cells against BCMA for the treatment of Multiple myeloma
CN112080568A (zh) *	2020-09-27	2020-12-15	扬州大学	一种与湖羊肌肉细胞增殖相关的miRNA标志物及其检测引物和应用
JP7740733B2 (ja) *	2021-08-31	2025-09-17	国立大学法人大阪大学	２型糖尿病・大腸がんを検査する方法
WO2023036266A1 (fr) *	2021-09-08	2023-03-16	Guangdong Jiyin Biotech Co. Ltd	Compositions et méthodes pour le diagnostic du cancer colorectal
CN113981096A (zh) *	2021-11-30	2022-01-28	无锡市疾病预防控制中心	一种用于诊断结直肠癌的血浆miRNA标志物及其应用
CN114672560B (zh) *	2022-01-12	2025-09-26	北京艾克伦医疗科技有限公司	通过外泌体miRNA标志物鉴定结直肠癌状态的检测试剂盒和方法
US20250197946A1 (en)	2022-05-20	2025-06-19	Novigenix Sa	Biomarkers for colorectal neoplasia
CN119144728B (zh) *	2024-11-19	2025-04-29	四川大学华西医院	原发性肝癌的MicroRNA标志物的引物、试剂盒和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4965188A (en)	1986-08-22	1990-10-23	Cetus Corporation	Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
GB0415277D0 (en) *	2004-07-07	2004-08-11	Colonix Ltd	Apparatus and method for sampling mucosal surfaces
US7939255B2 (en)	2006-07-03	2011-05-10	Catholic University Industry Academy Cooperation Foundation	Diagnostic methods for colorectal cancer
WO2008055158A2 (fr) *	2006-10-30	2008-05-08	University Of South Alabama	Microarn en tant que biomarqueur dans le cancer
US8252538B2 (en)	2006-11-01	2012-08-28	The Ohio State University	MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
BRPI0818146A2 (pt) *	2007-10-30	2015-07-14	Veridex Llc	Processo para monitorar câncer colorretal
CN101424640B (zh) *	2007-11-02	2012-07-25	江苏命码生物科技有限公司	血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法
WO2009111643A2 (fr) *	2008-03-06	2009-09-11	Asuragen, Inc.	Marqueurs microrna pour la récurrence d’un cancer colorectal
EP2283161A4 (fr) *	2008-05-16	2012-03-28	Veridex Llc	Procédé d'évaluation du cancer colorectal et compositions utilisables à cet effet
WO2010004562A2 (fr)	2008-07-09	2010-01-14	Rosetta Genomics Ltd.	Procédés et compositions permettant de détecter un cancer colorectal
CA2743211A1 (fr) *	2008-11-12	2010-05-20	Caris Life Sciences Luxembourg Holdings, S.A.R.L.	Procedes et systemes d'utilisation d'exosomes pour determiner des phenotypes
WO2010055487A2 (fr) *	2008-11-13	2010-05-20	Koninklijke Philips Electronics N.V.	Compositions et procédés pour le profilage de l'expression des microarn du cancer colorectal
WO2010126355A1 (fr) *	2009-04-29	2010-11-04	Academisch Medisch Centrum Bij De Universiteit Van Amsterdam	Moyens et procédés pour contrecarrer, prévenir et/ou déterminer une insuffisance cardiaque ou un risque d'insuffisance cardiaque
EP2336353A1 (fr) *	2009-12-17	2011-06-22	febit holding GmbH	Empreinte miARN dans le diagnostic des maladies
US20100317533A1 (en)	2009-06-05	2010-12-16	British Columbia Cancer Agency Branch	Biomarkers of cancer metastasis
WO2011012136A1 (fr)	2009-07-28	2011-02-03	Exiqon A/S	Procédé de classification d'un échantillon de cellules humaines comme cancéreux
CN101988060A (zh) *	2009-07-30	2011-03-23	江苏命码生物科技有限公司	结直肠癌检测标记物及其检测方法、试剂盒和生物芯片
WO2011044541A2 (fr) *	2009-10-09	2011-04-14	Baylor Research Institute	Identification de microarn (miarn) dans des échantillons fécaux comme biomarqueurs des cancers de l'appareil digestif
WO2011076142A1 (fr) *	2009-12-24	2011-06-30	Fudan University	Compositions et procédés pour le profilage de l'expression de micro-arn dans un plasma d'un cancer colorectal
WO2011076147A1 (fr)	2009-12-24	2011-06-30	Fudan University	Biomarqueurs et méthodes à microarn plasmatiques utilisés pour la détection précoce du cancer colorectal
US20140148348A1 (en)	2010-01-13	2014-05-29	Christine Kuslich	Dectection of gastrointestinal disorders
TW201207395A (en) *	2010-06-23	2012-02-16	Univ Hong Kong Chinese	Micro-RNA markers for colorectal cancer

2009
- 2009-04-01 NO NO16160669A patent/NO3051026T3/no unknown
2012
- 2012-10-20 PT PT12852462T patent/PT2768986T/pt unknown
- 2012-10-20 KR KR1020147013663A patent/KR101900872B1/ko active Active
- 2012-10-20 AU AU2012356317A patent/AU2012356317B2/en active Active
- 2012-10-20 BR BR112014009643-0A patent/BR112014009643B1/pt active IP Right Grant
- 2012-10-20 CN CN201280064096.7A patent/CN104145024A/zh active Pending
- 2012-10-20 MX MX2015002910A patent/MX357119B/es unknown
- 2012-10-20 DK DK15158185.7T patent/DK2944700T3/en active
- 2012-10-20 CA CA2852850A patent/CA2852850C/fr active Active
- 2012-10-20 US US13/656,690 patent/US20130102487A1/en not_active Abandoned
- 2012-10-20 DK DK12852462.6T patent/DK2768986T3/en active
- 2012-10-20 JP JP2014536355A patent/JP6159727B2/ja active Active
- 2012-10-20 EP EP12852462.6A patent/EP2768986B1/fr active Active
- 2012-10-20 WO PCT/IB2012/003035 patent/WO2013093635A2/fr not_active Ceased
- 2012-10-20 PL PL15158185T patent/PL2944700T3/pl unknown
- 2012-10-20 PT PT151581857T patent/PT2944700T/pt unknown
- 2012-10-20 ES ES15158185.7T patent/ES2662401T3/es active Active
- 2012-10-20 US US14/352,462 patent/US20150087525A1/en not_active Abandoned
- 2012-10-20 PL PL12852462T patent/PL2768986T3/pl unknown
- 2012-10-20 BR BR122015004941-5A patent/BR122015004941B1/pt active IP Right Grant
- 2012-10-20 RU RU2015108970A patent/RU2662975C1/ru active
- 2012-10-20 CN CN201510098369.5A patent/CN104651521B/zh active Active
- 2012-10-20 IN IN1855DEN2015 patent/IN2015DN01855A/en unknown
- 2012-10-20 RU RU2014120427A patent/RU2611189C2/ru active
- 2012-10-20 MX MX2014004810A patent/MX357550B/es active IP Right Grant
- 2012-10-20 HU HUE15158185A patent/HUE035614T2/en unknown
- 2012-10-20 EP EP15158185.7A patent/EP2944700B1/fr active Active
- 2012-10-20 KR KR1020157005756A patent/KR101912731B1/ko active Active
- 2012-10-20 HU HUE12852462A patent/HUE039522T2/hu unknown
- 2012-10-20 ES ES12852462.6T patent/ES2688693T3/es active Active
2015
- 2015-03-05 JP JP2015043433A patent/JP6203209B2/ja active Active
- 2015-03-05 US US14/639,539 patent/US20150176082A1/en not_active Abandoned
2016
- 2016-06-14 US US15/181,578 patent/US20160289771A1/en not_active Abandoned
2018
- 2018-06-28 US US16/022,597 patent/US20180346996A1/en active Pending
- 2018-08-08 US US16/058,940 patent/US20180355439A1/en active Pending

Also Published As

Publication number	Publication date
BR112014009643A2 (pt)	2017-12-12
CN104651521A (zh)	2015-05-27
US20150176082A1 (en)	2015-06-25
EP2944700A1 (fr)	2015-11-18
MX2014004810A (es)	2014-11-25
NO3051026T3 (fr)	2018-07-28
PL2768986T3 (pl)	2018-12-31
PL2944700T3 (pl)	2018-05-30
US20180346996A1 (en)	2018-12-06
PT2768986T (pt)	2018-10-23
ES2662401T3 (es)	2018-04-06
DK2944700T3 (en)	2018-01-22
CA2852850A1 (fr)	2013-06-27
JP2015128442A (ja)	2015-07-16
MX357119B (es)	2018-06-27
AU2012356317B2 (en)	2016-04-07
EP2944700B1 (fr)	2017-10-18
EP2768986B1 (fr)	2018-06-27
RU2611189C2 (ru)	2017-02-21
BR122015004941A2 (pt)	2019-08-20
CN104651521B (zh)	2021-08-27
CA2852850C (fr)	2020-07-28
US20180355439A1 (en)	2018-12-13
BR122015004941B1 (pt)	2021-09-28
JP2014530619A (ja)	2014-11-20
WO2013093635A2 (fr)	2013-06-27
WO2013093635A3 (fr)	2013-09-06
PT2944700T (pt)	2018-01-24
US20150087525A1 (en)	2015-03-26
HUE039522T2 (hu)	2019-01-28
KR101900872B1 (ko)	2018-09-20
KR101912731B1 (ko)	2018-10-29
MX357550B (es)	2018-07-13
CN104145024A (zh)	2014-11-12
RU2014120427A (ru)	2015-11-27
KR20140097195A (ko)	2014-08-06
BR112014009643B1 (pt)	2020-12-15
RU2662975C1 (ru)	2018-07-31
EP2768986A2 (fr)	2014-08-27
HUE035614T2 (en)	2018-05-28
AU2012356317A1 (en)	2014-05-15
DK2768986T3 (en)	2018-09-10
JP6203209B2 (ja)	2017-09-27
US20160289771A1 (en)	2016-10-06
KR20150036804A (ko)	2015-04-07
US20130102487A1 (en)	2013-04-25
JP6159727B2 (ja)	2017-07-05
ES2688693T3 (es)	2018-11-06

Publication	Publication Date	Title
IN2015DN01855A (fr)	2015-07-10
NZ593514A (en)	2013-03-28	p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
NZ607282A (en)	2014-06-27	Method for using gene expression to determine prognosis of prostate cancer
IN2013CN01129A (fr)	2015-07-31
WO2010096154A3 (fr)	2011-01-06	Compositions et méthodes de diagnostic et de pronostic de cancer colorectal
WO2012096545A3 (fr)	2013-03-07	Nouveau biomarqueur du cancer du pancréas utilisant les caractéristiques des cellules souches du cancer du pancréas, et son utilisation
EP4335932A3 (fr)	2024-06-26	Procédés de surveillance de conditions par analyse de séquence
MX390772B (es)	2025-03-21	Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
WO2013062931A3 (fr)	2013-07-18	Dosage à base de balises moléculaires pour la détection de biomarqueurs de métastases d'un cancer du sein
NZ599194A (en)	2014-07-25	Methods to predict clinical outcome of cancer
WO2012047899A3 (fr)	2012-07-05	Nouveaux biomarqueurs de diagnostic de cancer colorectal par l'hyperméthylation de l'adn
NZ599456A (en)	2014-06-27	Assays for the detection of anti-tnf drugs and autoantibodies
BR112012011230A2 (pt)	2016-04-05	fatores de risco e previsão de infarto do miocárdio
WO2012027631A3 (fr)	2012-07-19	Méthodes pour la détection d'anticorps anti-he4 et méthodes de diagnostic et/ou de pronostic d'états associés à des cellules exprimant he4
EP2619587A4 (fr)	2013-11-13	Biomarqueurs pour la prédiction de récurrence du cancer colorectal
WO2015091575A3 (fr)	2015-08-13	Niveaux différents de marqueurs emt dans des échantillons de cellules sanguines pour le diagnostic du cancer, en particulier du cancer colorectal (crc) et du cancer pancréatique (pc)
WO2011052906A3 (fr)	2011-10-13	Utilisation de eif3m pour le diagnostic et le traitement du cancer
WO2015077382A3 (fr)	2015-11-19	Test cytologique et moléculaire combiné pour la détection précoce d'adénocarcinome œsophagien
GB201222576D0 (en)	2013-01-30	Method for diagnosing lung cancer
HK1221504A1 (zh)	2017-06-02	用於前列腺癌的生物标志物检测中的方法和阵列
EP2415877A3 (fr)	2012-02-15	Moyens et procédés pour diagnostiquer un cancer pancréatique
WO2009099561A3 (fr)	2009-10-29	Peptides urinaires ca125 utilisés comme biomarqueurs du cancer de l’ovaire
EP3502702A3 (fr)	2019-07-10	Prévision de la récurrence du cancer de la vessie par signature de protéine dans des échantillons de tissus
GB201206323D0 (en)	2012-05-23	Methods and arrays for use in the same
WO2014044791A3 (fr)	2014-05-22	Procédés et trousses pour la prédiction de la sensibilité d'un sujet vis-à-vis d'une chimiothérapie